these data suggest that ceftazidime is effective as monotherapy in the treatment of skin , skin structure , bone , and joint infections , and that it may be more efficacious against staphylococcal infections than predicted from in vitro data .
C0007559
ceftazidime
C0038160
staphylococcal infections